Jeffrey S. Barrett
Jeffrey S. Barrett
Head, Quantitative Sciences, Bill & Melinda Gates Medical Research Institute
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
What is pharmacoepidemiology?
BL Strom
Pharmacoepidemiology, 1-26, 2019
MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man.
K Peerlinck, I De Lepeleire, M Goldberg, D Farrell, J Barrett, E Hand, ...
Circulation 88 (4), 1512-1517, 1993
Population pharmacokinetic studies in pediatrics: issues in design and analysis
B Meibohm, S Läer, JC Panetta, JS Barrett
The AAPS journal 7 (2), E475-E487, 2005
Pharmacokinetics and pharmacodynamics of MK‐383, a selective non‐peptide platelet glycoprotein‐IIb/IIIa receptor antagonist, in healthy men
JS Barrett, G Murphy, K Peerlinck, ID Lepeleire, RJ Gould, D Panebianco, ...
Clinical Pharmacology & Therapeutics 56 (4), 377-388, 1994
Shortening the timeline of pediatric phase I trials: the rolling six design
JM Skolnik, JS Barrett, B Jayaraman, D Patel, PC Adamson
Journal of Clinical Oncology 26 (2), 190-195, 2008
Physiologically based pharmacokinetic (PBPK) modeling in children
JS Barrett, O Della Casa Alberighi, S Läer, B Meibohm
Clinical Pharmacology & Therapeutics 92 (1), 40-49, 2012
Population pharmacokinetics of fluconazole in young infants
KC Wade, D Wu, DA Kaufman, RM Ward, DK Benjamin, JE Sullivan, ...
Antimicrobial agents and chemotherapy 52 (11), 4043-4049, 2008
Population pharmacokinetics and pharmacodynamics of ciclesonide
S Rohatagi, V Arya, K Zech, R Nave, G Hochhaus, BK Jensen, JS Barrett
The Journal of Clinical Pharmacology 43 (4), 365-378, 2003
Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6
BJ Gertz, JS Barrett, R Eisenhandler, DA Krupa, JM Wittreich, JR Seibold, ...
The Journal of Clinical Endocrinology & Metabolism 77 (5), 1393-1397, 1993
Moricizine bioavailability via simultaneous, dual, stable isotope administration: bioequivalence implications
HJ Pieniaszek Jr, M Mayersohn, MP Adams, RJ Reinhart, JS Barrett
The Journal of Clinical Pharmacology 39 (8), 817-825, 1999
Dosing in heavy-weight/obese patients with the LMWH, tinzaparin: a pharmacodynamic study
JW Hainer, JS Barrett, CA Assaid, MJ Fossler, DS Cox, T Leathers, ...
Thrombosis and haemostasis 87 (05), 817-823, 2002
Population pharmacokinetic meta-analysis with efavirenz.
JS Barrett, AS Joshi, M Chai, TM Ludden, WD Fiske, HJ Pieniaszek Jr
International journal of clinical pharmacology and therapeutics 40 (11), 507, 2002
Pharmacometrics: a multidisciplinary field to facilitate critical thinking in drug development and translational research settings
JS Barrett, MJ Fossler, KD Cadieu, MR Gastonguay
The Journal of Clinical Pharmacology 48 (5), 632-649, 2008
Separation and characterization of silybin, isosilybin, silydianin and silychristin in milk thistle extract by liquid chromatography–electrospray tandem mass spectrometry
JI Lee, BH Hsu, D Wu, JS Barrett
Journal of Chromatography A 1116 (1-2), 57-68, 2006
Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants
KC Wade, DK Benjamin Jr, DA Kaufman, RM Ward, PB Smith, ...
The Pediatric infectious disease journal 28 (8), 717, 2009
Application of physiologically based pharmacokinetic modeling to predict acetaminophen metabolism and pharmacokinetics in children
XL Jiang, P Zhao, JS Barrett, LJ Lesko, S Schmidt
CPT: pharmacometrics & systems pharmacology 2 (10), 1-9, 2013
The population pharmacokinetics of dexmedetomidine in infants after open heart surgery
F Su, SC Nicolson, MR Gastonguay, JS Barrett, PC Adamson, DS Kang, ...
Anesthesia and analgesia 110 (5), 1383, 2010
Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis
X Zuo, CM Ng, JS Barrett, A Luo, B Zhang, C Deng, L Xi, K Cheng, Y Ming, ...
Pharmacogenetics and genomics 23 (5), 251-261, 2013
Busulfan in infant to adult hematopoietic cell transplant recipients: a population pharmacokinetic model for initial and Bayesian dose personalization
JS McCune, MJ Bemer, JS Barrett, KS Baker, AS Gamis, NHG Holford
Clinical Cancer Research 20 (3), 754-763, 2014
Analysis and comparison of active constituents in commercial standardized silymarin extracts by liquid chromatography–electrospray ionization mass spectrometry
JI Lee, M Narayan, JS Barrett
Journal of Chromatography B 845 (1), 95-103, 2007
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20